AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
156.45
-0.79 (-0.50%)
At close: Aug 14, 2026, 4:00 PM EDT
156.50
+0.05 (0.03%)
After-hours: Aug 14, 2026, 7:58 PM EDT

AstraZeneca Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Buy" and an average price target of $213.69. The average 1-year stock price forecast is 36.59% higher than the current stock price, while the lowest is $184 (+17.61%) and the highest is $240 (+53.40%).

Price Target: $213.69 (+36.59%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$184$213.69$214.5$240
Change+17.61%+36.59%+37.10%+53.40%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy677766
Buy222223
Hold111121
Sell000000
Strong Sell000000
Total91010101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$223
BuyReiterates$223+42.26%Aug 7, 2026
Jefferies
Jefferies
Buy
Maintains
$236
BuyMaintains$236+50.88%Aug 7, 2026
Deutsche Bank
Deutsche Bank
Sell
Maintains
$155
SellMaintains$155-0.85%Aug 4, 2026
UBS
UBS
Buy
Maintains
$237
BuyMaintains$237+51.74%Aug 4, 2026
Citi
Citi
Buy
Maintains
n/a
BuyMaintainsn/an/aAug 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
63.25B
from 58.74B
Increased by 7.68%
Revenue Next Year
66.85B
from 63.25B
Increased by 5.70%
EPS This Year
10.26
from 9.16
Increased by 11.99%
EPS Next Year
11.44
from 10.26
Increased by 11.49%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
37.42B44.35B45.81B54.07B58.74B63.25B
Revenue Growth
40.58%18.53%3.29%18.04%8.63%7.68%
Gross Profit
25.41B35.71B37.77B44.44B47.99B52.21B
Gross Margin
67.92%80.52%82.44%82.18%81.71%82.54%
Operating Income
2.90B8.81B9.70B12.93B14.29B21.05B
Net Income
112.00M3.29B5.96B7.04B10.23B12.07B
EPS
----9.1610.26
EPS Growth
----11.57%11.99%
Forward PE
-----15.25
Dividend / Share
2.872.902.903.103.203.32
Dividend Growth
2.50%1.05%-6.90%3.23%3.90%
Free Cash Flow
-1.85B12.49B9.04B8.46B7.87B9.42B
No. Analysts
-----24
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High64.4B
Avg63.3B
Low62.4B

Revenue Growth

Revenue Growth202620272028
High
9.6%
Avg
7.7%
Low
6.2%

EPS Forecast

EPS202620272028
High10.58
Avg10.26
Low10.01

EPS Growth

EPS Growth202620272028
High
15.5%
Avg
12.0%
Low
9.3%